-
ECONOMIC IMPACT OF TARDIVE DYSKINESIA AMONG HOSPITALIZED SCHIZOPHRENIA PATIENTS: EVIDENCE FROM US ADMINISTRATIVE DATA
Mar 18, 2026, 21:38 PM -
A MULTI-AGENT GENAI SYSTEM FOR TRACEABLE, MULTI-COUNTRY LANDSCAPE ASSESSMENT IN MASH
Mar 18, 2026, 21:38 PM -
REAL-TIME AI-ASSISTED LIVING SYSTEMATIC LITERATURE REVIEW (REAL-SLR) CAPTURES A 2025 STANDARD-OF-CARE (SOC) SHIFT DRIVEN BY ANTIBODY-DRUG CONJUGATES (ADCS) IN UROTHELIAL CARCINOMA (UC): IMPLICATIONS FOR HEALTH TECHNOLOGY ASSESSMENTS (HTAS)
Mar 18, 2026, 21:38 PM -
COST-BENEFIT ANALYSIS OF TUMOR TREATING FIELDS PLUS RADIOSURGERY FOR BRAIN METASTASES FROM NON-SMALL CELL LUNG CANCER
Mar 18, 2026, 21:38 PM -
FAMILY IMPACT OF ADULT ANGELMAN SYNDROME: CAREGIVER PERSPECTIVES
Mar 18, 2026, 21:38 PM -
EFFECTIVENESS OF A CENTRALIZED COMMUNITY PHARMACY-BASED PATIENT ACCESS AND THERAPY MANAGEMENT PROGRAM FOR SPECIALTY-LITE MEDICATIONS: A NATIONAL REAL-WORLD STUDY
Mar 18, 2026, 21:38 PM -
REAL-WORLD EFFECTIVENESS OF STATIN THERAPY AND PREDICTIVE MODELING OF ADHERENCE AMONG PATIENTS WITH SEVERE HYPERCHOLESTEROLEMIA
Mar 18, 2026, 21:38 PM -
FROM DATA TO INSIGHTS: VALIDATING ARTIFICIAL INTELLIGENCE (AI)-GENERATED WRITING IN EVIDENCE SYNTHESIS
Mar 18, 2026, 21:38 PM -
EFFICACY AND EFFECTIVENESS OF IMMUNE CHECKPOINT INHIBITORS IN TRIPLE-NEGATIVE BREAST CANCER: A SYSTEMATIC LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
A REVIEW ON THE APPLICATION OF PATIENT-REPORTED OUTCOMES IN THE LABELING OF NEW ONCOLOGY DRUGS
Mar 18, 2026, 21:38 PM -
IMPACT OF A DIGITAL CARDIOVASCULAR MANAGEMENT PROGRAM ON HEALTHCARE COSTS AND UTILIZATION IN PATIENTS WITH HEART FAILURE: A PROPENSITY-MATCHED COHORT ANALYSIS
Mar 18, 2026, 21:38 PM -
PROJECTED IMPACT OF PERSONALIZED MRNA NEOANTIGEN CANCER VACCINES IN MEDICARE: A SCENARIO ANALYSIS USING TRIAL EFFICACY AND LINKED DATA POPULATION ESTIMATES
Mar 18, 2026, 21:38 PM -
REAL-WORLD COST-EFFECTIVENESS AND OPPORTUNITY COSTS OF ANTI-IL-17/23 VERSUS ANTI-TNF? THERAPIES FOR PSORIASIS USING DLQI
Mar 18, 2026, 21:38 PM -
PREVALENCE AND HEALTHCARE BURDEN OF COMPLICATED URINARY TRACT INFECTIONS AMONG HOSPITALIZED PATIENTS IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
CHARACTERIZING GLOBAL ISPOR STUDENT PARTICIPATION: A NORTH AMERICA VS. REST OF WORLD COMPARISON
Mar 18, 2026, 21:38 PM -
WHEN THE TAIL WAGS THE DOG: RETHINKING PARTITIONED SURVIVAL MODELLING IN ONCOLOGY
Mar 18, 2026, 21:38 PM -
ESTIMATION OF HEALTH-STATE UTILITY VALUES IN PHENYLKETONURIA (PKU), VIA CLINICAL-EXPERT PROXY ASSESSMENT WITH A GENERIC MEASURE (SF-12V2) OF PATIENT-REPORTED IMPACTS FROM A DISEASE-SPECIFIC MEASURE (PKU-QOL): INTERIM RESULTS
Mar 18, 2026, 21:38 PM -
PREPARING FOR THE NEXT ACCESS PARADIGM: TRANSITIONING FROM A REBATE-DOMINANT MARKET TO EU-STYLE EVIDENCE-BASED VALUE TO MAXIMIZE US PAYER COVERAGE
Mar 18, 2026, 21:38 PM -
COST-CONSEQUENCE ANALYSIS OF UPADACITINIB FOR THE TREATMENT OF MODERATE-TO-SEVERE ATOPIC DERMATITIS IN COLOMBIA
Mar 18, 2026, 21:38 PM -
AUTHOR
Mar 18, 2026, 21:38 PM
